Epitranscriptomic regulation in cholangiocarcinoma: mechanisms and therapeutic implications

Maoyun Liu, Fengsheng Dai, Sheng Wang, Yi Wang, Cheng Zhang, Yuqin Xie, Ai Shen, Hengbin Wang, Dewei Li, Hui Li

Open source

DOI
10.1186/s12967-026-08740-8
Published
2026-08-11
Container
Journal of Translational Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-026-08740-8,
  title = {Epitranscriptomic regulation in cholangiocarcinoma: mechanisms and therapeutic implications},
  author = {Maoyun Liu and Fengsheng Dai and Sheng Wang and Yi Wang and Cheng Zhang and Yuqin Xie and Ai Shen and Hengbin Wang and Dewei Li and Hui Li},
  year = {2026},
  journal = {Journal of Translational Medicine},
  doi = {10.1186/s12967-026-08740-8},
  url = {https://doi.org/10.1186/s12967-026-08740-8}
}

RIS

TY  - JOUR
TI  - Epitranscriptomic regulation in cholangiocarcinoma: mechanisms and therapeutic implications
AU  - Maoyun Liu
AU  - Fengsheng Dai
AU  - Sheng Wang
AU  - Yi Wang
AU  - Cheng Zhang
AU  - Yuqin Xie
AU  - Ai Shen
AU  - Hengbin Wang
AU  - Dewei Li
AU  - Hui Li
PY  - 2026
JO  - Journal of Translational Medicine
DO  - 10.1186/s12967-026-08740-8
UR  - https://doi.org/10.1186/s12967-026-08740-8
ER  - 

APA

Liu, M., Dai, F., Wang, S., Wang, Y., Zhang, C., Xie, Y., Shen, A., Wang, H., Li, D., & Li, H. (2026). Epitranscriptomic regulation in cholangiocarcinoma: mechanisms and therapeutic implications. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-08740-8

Source records